Journals / Akademik Gastroenteroloji Dergisi / 2019 / Cilt: 18 - Sayı: 3

Expression of vitamin D receptor in colorectal cancer staging and its effects on prognosis

Vitamin D reseptör ekspresyonunun kolorektal kanserlerde evre ile ilişkisi ve prognoz üzerine etkisi

Pages
101–108
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Besides vitamin D receptor expression, receptor polymorphisms and mutations at the routes of re-ceptor affection and investigation of other factors would be beneficial.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Aims: The aim of the study was to evaluate the effects of vitamin D receptor expression on the prognosis and stag-ing of colorectal cancer.
📊
Key Findings & Data:Materials and Methods: Pathological speci-mens of 115 patients diagnosed with colorectal cancer were analyzed.
💡
Conclusion & Impact:Besides vitamin D receptor expression, receptor polymorphisms and mutations at the routes of re-ceptor affection and investigation of other factors would be beneficial.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Aims: The aim of the study was to evaluate the effects of vitamin D receptor expression on the prognosis and stag-ing of colorectal cancer. Materials and Methods: Pathological speci-mens of 115 patients diagnosed with colorectal cancer were analyzed. Perinuclear vitamin D receptors were immunohistochemically analyzed with 9A7 IgG2b monoclonal antibody. Results: Vitamin D receptor positivity, serosa infiltration, metastatic lymph node involvement, re-lapse period, and staging relationship was not statistically significant. Survival was found to be better in vitamin D receptor-positive patients than in vitamin D receptor-negative patients; however, the results were not statistically significant. Vitamin D receptor-positive patients could not achieve median survival, but their 5-year survival was found to be 43.3%. Vitamin D receptor-negative patients achieved a median sur-vival of 60 months, and the 5-year survival was 56.8%. Survival with-out disease was not significant based on vitamin D receptor positivity. There was no significant difference in disease-free survival between vitamin D receptor-positive and vitamin D receptor-negative patients (p = 0.053). Conclusion: Colorectal cancer prognosis was not affected with vitamin D receptor expression alone. Besides vitamin D receptor expression, receptor polymorphisms and mutations at the routes of re-ceptor affection and investigation of other factors would be beneficial.

Özet

Giriş ve Amaç: Kolorektal kanser hücrelerinde vitamin D reseptör eks-presyonunun tespiti ve bu reseptör ekspresyon derecesi ile kolorektal kanser prognoz ve evresinin ilişkisi olup olmadığını tespit etmektir. Gereç ve Yöntem: Çalışmaya 2003-2009 tarihleri arasında Ankara Üniversitesi Tıp Fakültesi Genel Cerrahi Bölümünde opere olmuş, Ankara Üniversitesi Tıp Fakültesi Patoloji Bölümünde kolon ve rektum kanseri tanısı konu-lup medikal tedavisi aynı üniversitenin Tıbbi Onkoloji Bölümünce yapılan hastalar dahil edilmiştir. Vitamin D reseptörlerinin değerlendirilmesi için seçilen olguların hematoksilen ve eozin kesitleri yeniden değerlendirildi. Vitamin D reseptör tayininde 9A7 immünoglobulin G2b monoklonal anti-kor boyaması kullanıldı. Bulgular: Çalışmaya 64’ü (%55.7) erkek ve 51’i (%44.3) kadın olmak üzere toplam 115 hasta alındı. Vitamin D reseptörü pozitif olan hastalarda genel sağ kalım istatistiksel olarak anlamlı olmasa da reseptör negatif olanlara göre daha iyi bulunmuştur. Vitamin D resep-tör pozitif olanlarda medyan sağ kalıma ulaşılamamıştır. 5 yıllık sağ kalım %69.4 oranında saptanmıştır. Vitamin D reseptör negatif olanlarda med-yan sağ kalım 60 ay olarak saptanmıştır. 5 yıllık sağ kalım %32 oranında bulunmuştur. Vitamin D reseptör negatif olanlarda 5 yıllık hastalıksız sağ kalım %56.8 bulunurken, vitamin D reseptör pozitif olanlarda hastalıksız sağ kalım %43.3 bulunmuştur. Vitamin D reseptör pozitif ve negatif olanlar arasında hastalıksız sağ kalım açısından istatiksel olarak anlamlı fark saptanmamıştır (p: 0.053). Sonuç: Vitamin D reseptör ekspresyonu-nun kolorektal kanser prognozu üzerine olan etkisinin tek başına anlamlı olmadığı saptanmıştır. Reseptör ekspresyonu dışında reseptör polimor-fizminin ve reseptörün etkilediği yolaklarda rol oynayan mutasyonların da prognozu belirlemede etkili olabileceği kanısına varılmıştır.

🔖

Cite This Article

PEPELER, M. S., SAVAŞ, B., PAMUKÇUOĞLU, M., TÖRÜNER, M., AKBULUT, H. (2019). Expression of vitamin D receptor in colorectal cancer staging and its effects on prognosis. Akademik Gastroenteroloji Dergisi, Cilt: 18 - Sayı: 3, 101–108. https://ajindex.com/articles/141696

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Simboli-Campbell M, Gagnon A, Franks DJ, Welsh J. 1,25-Dihy-droxyvitamin D3 translocates protein kinase C beta to nucleus and enhances plasma membrane association of protein kinase C alpha in renal epithelial cells. J Biol Chem 1994;269:3257-64
  2. Diaz GD, Paraskeva Ci Thomas MG, Binderup L, Hague A. Apopto-sis is induced by the active metabolite of vitamin D3 and its ana-logue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 2000;60:2304-12
  3. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vita-min D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325-49
  4. Barsony J, Pike W, DeLuca HF, Marx SJ. Immunocytology with microwave-fixed fibroblasts shows 1 alpha,25-dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors. J Cell Biol 1990;111:2385-95
  5. Fedirko V, Bostiak RM, Long Q, et al. Effects of supplemental vi-tamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010;19: 280-91
  6. Freedman LP. Transcriptional targets of the vitamin D3 receptor-me-diating cell cycle arrest and differentiation. J Nutr 1999;129(2S Suppl):581S-586S
  7. Zehnder D, Bland R, Williams MC, et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Me-tab 2001;86:888-94
  8. Hsu JY, Feldman D, McNeal JE, Peehl DM. Reduced 1alpha-hy-droxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res 2001;61:2852-6
  9. Friedrich M, Diesing D, Cordes T, et al. Analysis of 25-hydroxyvita-min D3-1alpha-hydroxylase in normal and malignant breast tissue. Anticancer Res 2006;26:2615-20
  10. Matusiak D, Murillo G, Carroll RE, Mehta RG, Benya RV. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxy-lase in normal and malignant human colon. Cancer Epidemiol Bio-markers Prev 2005;14:2370-6
  11. Lointier P, Wargovich MJ, Saez S, et al. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro. Antican-cer Res 1987;7:817-21
  12. Shabahang M, Buras RR, Davodi F, et al. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differenti-ation and growth inhibition. Cancer Res 1993;53:3712-8
  13. Sheinin Y, Kaserer K, Wrba F, et al. In situ mRNA hybrid